169 related articles for article (PubMed ID: 24252546)
21. Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists.
Allan AC; Billinton A; Brown SH; Chowdhury A; Eatherton AJ; Fieldhouse C; Giblin GM; Goldsmith P; Hall A; Hurst DN; Naylor A; Rawlings DA; Sime M; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2011 Jul; 21(14):4343-8. PubMed ID: 21676612
[TBL] [Abstract][Full Text] [Related]
22. Synthesis, biological evaluation and 3D-QSAR study of novel 4,5-dihydro-1H-pyrazole thiazole derivatives as BRAF(V⁶⁰⁰E) inhibitors.
Zhao MY; Yin Y; Yu XW; Sangani CB; Wang SF; Lu AM; Yang LF; Lv PC; Jiang MG; Zhu HL
Bioorg Med Chem; 2015 Jan; 23(1):46-54. PubMed ID: 25496804
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiviral activity of new pyrazole and thiazole derivatives.
el-Sabbagh OI; Baraka MM; Ibrahim SM; Pannecouque C; Andrei G; Snoeck R; Balzarini J; Rashad AA
Eur J Med Chem; 2009 Sep; 44(9):3746-53. PubMed ID: 19419804
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of some substituted 1H-pyrazolyl-oxazolidines or 1H-pyrazolyl-thiazolidines as anti-inflammatory-antimicrobial agents.
Bekhit AA; Fahmy HT
Arch Pharm (Weinheim); 2003 Apr; 336(2):111-8. PubMed ID: 12761764
[TBL] [Abstract][Full Text] [Related]
25. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives containing benzodioxole as potential anticancer agents.
Wang HH; Qiu KM; Cui HE; Yang YS; Yin-Luo ; Xing M; Qiu XY; Bai LF; Zhu HL
Bioorg Med Chem; 2013 Jan; 21(2):448-55. PubMed ID: 23245802
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of the 1-arylpyrazole class of σ(1) receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862).
Díaz JL; Cuberes R; Berrocal J; Contijoch M; Christmann U; Fernández A; Port A; Holenz J; Buschmann H; Laggner C; Serafini MT; Burgueño J; Zamanillo D; Merlos M; Vela JM; Almansa C
J Med Chem; 2012 Oct; 55(19):8211-24. PubMed ID: 22784008
[TBL] [Abstract][Full Text] [Related]
28. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
[TBL] [Abstract][Full Text] [Related]
29. Reinvestigating the reaction of 1H-pyrazol-5-amines with 4,5-dichloro-1,2,3-dithiazolium chloride: a route to pyrazolo[3,4-c]isothiazoles and pyrazolo[3,4-d]thiazoles.
Koyioni M; Manoli M; Manos MJ; Koutentis PA
J Org Chem; 2014 May; 79(9):4025-37. PubMed ID: 24734990
[TBL] [Abstract][Full Text] [Related]
30. Facile regioselective synthesis of novel bioactive thiazolyl-pyrazoline derivatives via a three-component reaction and their antimicrobial activity.
Sharifzadeh B; Mahmoodi NO; Mamaghani M; Tabatabaeian K; Chirani AS; Nikokar I
Bioorg Med Chem Lett; 2013 Jan; 23(2):548-51. PubMed ID: 23228471
[TBL] [Abstract][Full Text] [Related]
31. 2-(1H-Pyrazol-4-yl)acetic acids as CRTh2 antagonists.
Andrés M; Bravo M; Buil MA; Calbet M; Castro J; Domènech T; Eichhorn P; Ferrer M; Gómez E; Lehner MD; Moreno I; Roberts RS; Sevilla S
Bioorg Med Chem Lett; 2013 Jun; 23(11):3349-53. PubMed ID: 23601708
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
33. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
34. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships and in vivo activity of (1H-pyrazol-4-yl)acetamide antagonists of the P2X(7) receptor.
Beswick PJ; Billinton A; Chambers LJ; Dean DK; Fonfria E; Gleave RJ; Medhurst SJ; Michel AD; Moses AP; Patel S; Roman SA; Roomans S; Senger S; Stevens AJ; Walter DS
Bioorg Med Chem Lett; 2010 Aug; 20(15):4653-6. PubMed ID: 20579878
[TBL] [Abstract][Full Text] [Related]
36. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
Demir Y; Taslimi P; Koçyiğit ÜM; Akkuş M; Özaslan MS; Duran HE; Budak Y; Tüzün B; Gürdere MB; Ceylan M; Taysi S; Gülçin İ; Beydemir Ş
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000118. PubMed ID: 32761859
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, biological evaluation and molecular modeling of dihydro-pyrazolyl-thiazolinone derivatives as potential COX-2 inhibitors.
Qiu KM; Yan R; Xing M; Wang HH; Cui HE; Gong HB; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(22):6648-54. PubMed ID: 23062711
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of 3,5-diaryl-4,5-dihydro-1H-pyrazoles as new tyrosinase inhibitors.
Zhou Z; Zhuo J; Yan S; Ma L
Bioorg Med Chem; 2013 Apr; 21(7):2156-62. PubMed ID: 23391365
[TBL] [Abstract][Full Text] [Related]
39. Identification of benzoxazin-3-one derivatives as novel, potent, and selective nonsteroidal mineralocorticoid receptor antagonists.
Hasui T; Matsunaga N; Ora T; Ohyabu N; Nishigaki N; Imura Y; Igata Y; Matsui H; Motoyaji T; Tanaka T; Habuka N; Sogabe S; Ono M; Siedem CS; Tang TP; Gauthier C; De Meese LA; Boyd SA; Fukumoto S
J Med Chem; 2011 Dec; 54(24):8616-31. PubMed ID: 22074142
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, benzodiazepine receptor binding and molecular modelling of isochromeno[4,3-c]pyrazol-5(1H)-one derivatives.
Maggio B; Raffa D; Raimondi MV; Plescia F; Trincavelli ML; Martini C; Meneghetti F; Basile L; Guccione S; Daidone G
Eur J Med Chem; 2012 Aug; 54():709-20. PubMed ID: 22795832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
